Why is Shukra Pharma. falling/rising?

As of 05-Sep, Shukra Pharmaceuticals Ltd is currently priced at Rs. 27.80, reflecting a decrease of Rs. 0.56 or 1.97%. The stock has recently reached a new 52-week high of Rs. 28.92 but has fallen after 13 consecutive days of gains. Despite this decline, the stock has shown strong performance over various periods, with a 1-week return of 6.03%, a 1-month return of 39.84%, and an impressive year-to-date return of 103.86%. However, it underperformed its sector by 1.9% today, and there has been a significant drop in investor participation, with delivery volume falling by 53.44% compared to the 5-day average. The company maintains a low Debt to EBITDA ratio of 1.28 times and has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 62.04%.
In the broader market context, Shukra Pharmaceuticals has outperformed the benchmark Sensex over the past week, month, year, and three years, indicating strong relative performance. The Sensex has only increased by 1.13% in the last week, contrasting with Shukra's 6.03% gain. Despite the recent price drop, the stock's long-term returns remain robust, with a staggering 337.80% increase over the past year, outperforming the BSE500 consistently. The liquidity of the stock is adequate for trading, which may help stabilize its price in the face of recent declines.